Innoviva (INVA) Misses Q4 EPS by 6c

Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.06 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $91.81 million versus the consensus estimate of $84.3 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lion Copper & Gold names Millie Paredes as CFO and corporate secretary
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer